Basit öğe kaydını göster

dc.contributor.authorAL-HAMAQ, A. O. A. A.
dc.contributor.authorBener, Abdulbari
dc.date.accessioned2021-03-05T15:09:54Z
dc.date.available2021-03-05T15:09:54Z
dc.date.issued2016
dc.identifier.citationBener A., AL-HAMAQ A. O. A. A. , "Predictions Burden of Diabetes and Economics Cost: Contributing Risk Factors of Changing Disease Prevalence and its Pandemic Impact to Qatar", EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, cilt.124, ss.504-511, 2016
dc.identifier.issn0947-7349
dc.identifier.otherav_ba903404-cb3c-4945-88ed-3e271bc417c9
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/124086
dc.identifier.urihttps://doi.org/10.1055/s-0042-103683
dc.description.abstractBackground: The Middle East region is predicted to have one of the highest prevalence of diabetes mellitus (DM) in the world. The risk of diabetes continues to increase worldwide and its public health burden is unevenly distributed across socioeconomic strata. This burden is not only related to health care costs, but also to indirect costs caused by loss of productivity from disability and premature mortality.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectEndokrinoloji ve Metabolizma Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectENDOKRİNOLOJİ VE METABOLİZMA
dc.titlePredictions Burden of Diabetes and Economics Cost: Contributing Risk Factors of Changing Disease Prevalence and its Pandemic Impact to Qatar
dc.typeMakale
dc.relation.journalEXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
dc.contributor.departmentQatar Diabet Assoc , ,
dc.identifier.volume124
dc.identifier.issue8
dc.identifier.startpage504
dc.identifier.endpage511
dc.contributor.firstauthorID96667


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster